EUVIMEDEUVIMED entdecken
Crossref

FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection

Samantha Anderer

JAMA · 07.07.2026 · 336 (1) · 9

DOI: 10.1001/jama.2026.8292 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 07.07.2026. Verfasst von Samantha Anderer.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Anderer, S. (2026). FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection. JAMA, 336(1), 9. https://doi.org/10.1001/jama.2026.8292

Vancouver

Anderer S. FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection. JAMA. 2026;336(1):9. doi:10.1001/jama.2026.8292

BibTeX
@article{Anderer2026,
  author = {Anderer, Samantha},
  title = {FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection},
  journal = {JAMA},
  year = {2026},
  volume = {336},
  number = {1},
  pages = {9},
  doi = {10.1001/jama.2026.8292}
}
Kostenlos starten →